Hypothesize That! Podcast Por UCB Biopharma arte de portada

Hypothesize That!

Hypothesize That!

De: UCB Biopharma
Escúchala gratis

Acerca de esta escucha

Welcome to Hypothesize That!, the UCB science podcast where science meets conjecture and curiosity, and the biggest ‘What If’s’ come to life. Join host Nicola Hill as she delves into the most provocative trends, theories, and questions shaping the future of discovery and development with top scientists, industry leaders, and patient advocates. From the transformative power of AI and virtual labs to the rise of decentralized clinical trials and patient-centred gene therapies, each episode tackles the biggest questions shaping pharma's future.

Hosted on Acast. See acast.com/privacy for more information.

UCB Biopharma
Ciencia Ciencias Biológicas Historia Natural Naturaleza y Ecología
Episodios
  • Episode 2 (BONUS): Crimes Against Innovation - Theranos Deception vs. Incrementalism’s Trap
    Jun 10 2025

    In the shadowy corridors of laboratories and the silent pages of medical journals, there lie tales that have seldom been told. Tales of ambition that flew too close to the sun, of genius that turned into folly, and of innovation that... well, wasn't quite so innovative. This is—Crimes Against Innovation.

    Join Craig Lipset and Lewis Millen as they argue two distinct crimes against innovation. Lewis takes on the Theranos scandal, a cautionary tale of deceit in healthcare, while Craig reflects on how corporate culture can slow down and even stop innovation trials. Host Nicola Hill must choose the most compelling case.

    This podcast is produced and funded by UCB.

    Hosted on Acast. See acast.com/privacy for more information.

    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    9 m
  • Episode 2: Within the Next 10 Years, Will Traditional Clinical Trials be Obsolete?
    Jun 10 2025

    In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade.

    Joining her are Craig Lipset, Co-Chair of the Decentralized Trials and Research Alliance, and Lewis Millen, UCB’s Global Clinical Science and Operations Innovation Lead. Together, they unpack the plausibility, benefits and challenges of this shift, from inclusivity and patient convenience to technological hurdles and regulatory readiness. Is a hybrid model the future, or will decentralized clinical trials render old paradigms irrelevant?


    This podcast is produced and funded by UCB.

    Hosted on Acast. See acast.com/privacy for more information.

    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    29 m
  • Episode 1 (BONUS): Crimes Against Innovation - The Milestone Menace vs. The Hunger for Innovation
    Apr 14 2025

    Deep in the shadowy corridors of laboratories and the silent pages of medical journals, secrets lie waiting to be uncovered—tales of ambition that soared too high to the sun, ideas that derailed progress, and innovations that should never have seen the light of day. This is—Crimes Against Innovation.


    In this episode, Professor Russ Altman and Dr. Alistair Henry go head-to-head as they debate two major issues in healthcare innovation. Russ argues that rigid milestones in research hinder scientific creativity, while Alistair contends that over-resourcing stifles innovation. Host Nicola Hill decides which of these “crimes” deserves the title of the worst offender.


    This podcast is produced and funded by UCB.

    Hosted on Acast. See acast.com/privacy for more information.

    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    16 m
Todavía no hay opiniones